Authors
M Garcia-Retortillo, M J López Casanova, S Mínguez Masó, A Zapatero Ferrándiz, M Sala Serra, C Farriols Danés
Published in
Journal of healthcare quality research. Volume 42. Issue 2. Pages 101253. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
To develop and implement a therapeutic intensity level (NIT-Mar) scale in a hospital consortium and evaluate its use.
Adaptation of a therapeutic intensity scale through an expert panel and subsequent evaluation based on a retrospective observational study in patients who died from SARS-CoV-2 infection between March and June 2020 in a university hospital consortium. The following were analyzed: clinical characteristics, use and change of the scale, consensus in decision-making, and concordance between the assigned therapeutic intensity level and the therapeutic measures applied.
A total of 210 patients were included, with 74.8% assigned a NIT. No significant differences were found in age, gender, or comorbidities between patients with and without NIT. Decision-making consensus was achieved in 87.9% of cases, mainly among professionals (77%) and families (72.6%), but only in 12.7% with the patient. In 49.7% of cases, the NIT was modified during hospitalization. Concordance between the assigned NIT and applied treatments was 85.3%.
The NIT-Mar scale was widely used from its implementation, facilitating decision-making in high-demand healthcare settings. Its flexibility allowed adjustments in therapeutic intensity according to patient evolution. This tool can improve communication between teams, care planning and patient safety.
PMID:
43008380
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0